Phost’in Therapeutics and the Gianni Bonadonna Foundation To Present First Clinical Data on PhOx430, a First-In-Class GnT-V Inhibitor, at ESMO 2025
Montpellier, France and Milan, Italy – October 2025, 2nd
Montpellier, France and Milan, Italy – October 2025, 2nd
Montpellier, France – September 2025, 8th